France · Delayed Price · Currency is EUR Vicat Earnings Call Transcripts
Fiscal Year 2026
-
Strong first-half results with 10.8% organic sales growth and 13.6% EBITDA growth, driven by emerging markets and operational improvements. Upgraded 2026 guidance to 7%-9% growth in sales and EBITDA, with continued focus on deleveraging, climate initiatives, and digital transformation.
-
Strong organic sales growth of 8.5% in Q1 2026 was driven by price increases and volume recovery across all regions, despite significant FX and energy cost headwinds. Guidance for slight full-year growth in sales and EBITDA is maintained, with proactive price management to offset inflation.
Fiscal Year 2025
-
Revenue reached EUR 3.85 billion with 3.3% organic growth, and EBITDA was EUR 771 million at a 20% margin. Strong cash flow enabled deleveraging, while major projects in France, Senegal, and Brazil, plus climate initiatives, support future growth.
-
Q3 2025 saw 4.9% organic sales growth, with strong performance in Europe and the Mediterranean offsetting U.S. softness. Full-year guidance and deleveraging targets are maintained, despite FX headwinds and a revised leverage outlook. Key projects and disciplined capital allocation support long-term growth.
-
Stable organic sales and resilient profitability despite FX headwinds and volume declines in key regions. Updated 2025 EBITDA growth guidance to 2–5% like-for-like, with strong performance in Egypt, Brazil, and the Mediterranean, and continued focus on deleveraging and sustainability.
-
Stable like-for-like revenue in Q1 2025, with resilience in Western Europe offsetting slowdowns in India and Africa. 2025 guidance for sales and EBITDA growth is confirmed, supported by cost initiatives and new projects like CAN6 and Vaya.
Fiscal Year 2024
-
Record EBITDA and strong cash flow were achieved despite weak European markets, driven by US and Mediterranean growth, cost control, and decarbonization progress. Outlook targets continued margin strength, debt reduction, and climate investments, with key contributions expected from new projects in Senegal and the US.
-
Organic sales rose 3.3% over nine months, with strong U.S. growth offsetting European weakness and currency headwinds. EBITDA and leverage guidance for 2024 are maintained, while strategic moves in France and sustainability initiatives support future growth.
-
Organic growth of 4.8% and EBITDA up 12.3% in H1 2024, led by strong US and emerging market performance. Capex rose to €186M, with deleveraging and decarbonization as top priorities. Full-year EBITDA is guided to grow 3–8% over 2023.